Meredith Clement, MD
Enriched profileAssociate Professor (Clinical Associate Professor of Medicine, Infectious Diseases) · Louisiana State University Health Sciences Center New Orleans
Meredith Clement is Associate Professor (Clinical Associate Professor of Medicine, Infectious Diseases) at Louisiana State University Health Sciences Center New Orleans. OpenAlex indexes 92 publications with 3,105 citations (h-index 24); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 17 Aug 2026
Overview
Updated 14 Oct 2026
Meredith Clement, MD, is Associate Professor (Clinical Associate Professor of Medicine, Infectious Diseases) at Louisiana State University Health Sciences Center New Orleans (LSU Health Sciences Center School of Medicine). The public record shows 92 publications with 3,105 citations (h-index 24), centered on HIV/AIDS Research and Interventions, HIV, Drug Use, Sexual Risk, HIV-related health complications and treatments. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 3 companies, 1 NIH-funded awards (2018–2022).
- Most recent indexed publication: 2026 · The Journal of infectious diseases
- Top research focus: HIV/AIDS Research and Interventions
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 14 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 37.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Assessing the Feasibility and Preliminary Impact of a mHealth App on Reducing STI Risk in Black MSM PrEP Users
Sponsor: Louisiana State University Health Sciences Center in New Orleans
Industry payments
Updated 14 Oct 2026
3 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year20256 payments$15,720openpaymentsdata.cms.gov ↗
- ViiV Healthcare CompanyProgram year202511 payments
- Merck Sharp & Dohme LLCProgram year202510 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
32.6%Statin11.9%Atorvastatin Calcium85%Rosuvastatin Calcium9%Pravastatin Sodium7%Part D<11 patientsCalcium channel blocker5%Amlodipine Besylate100%Part D≥12 patients+ 6 more classes in this area
Anti-infectives
18.2%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor6.1%Tivicay69%Cabenuva18%Dovato13%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor5%Descovy43%Triumeq41%Abacavir16%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
14.9%Biguanide (metformin)5.1%Metformin Hcl84%Metformin Hcl Er16%Part D<11 patientsGLP-1 receptor agonist3%Rybelsus40%Ozempic38%Trulicity23%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
1 NIH research award on record, funded 2018–2022 per NIH RePORTER. The latest:
- A randomized controlled trial of doxycycline post exposure prophylaxis to prevent incident bacterial STIs among women in the United States
University of Alabama at Birmingham
FY2026$1,531,375R01AI196614 - Leveraging Local Health System Electronic Health Record Data to Enhance PrEP Access in Southeastern Louisiana: A Community-Informed Approach
Duke University
FY2026$684,092R01AI169641 - Leveraging Local Health System Electronic Health Record Data to Enhance PrEP Access in Southeastern Louisiana: A Community-Informed Approach
Duke University
FY2025$751,823R01AI169641
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- A New Type of Nonsuppressible Viremia Produced by HIV-Infected Macrophage.
The Journal of infectious diseases
Article2026 - Multi-Center Real-World Implementation Outcomes of Lenacapavir for HIV Pre-Exposure Prophylaxis.
Clinical infectious diseases
Article2026 - Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083.
Clinical infectious diseases
Article2026 - Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial Sexually Transmitted Infections: A Secondary Analysis of HPTN 083.
Clinical infectious diseases
Article2026 - HEalth Record Optimization for Identifying Candidates for HIV PRe-Exposure Prophylaxis: A Community-Informed Approach to Model Development.
AIDS patient care and STDs
Article2025
Most-cited works
by citation count (OpenAlex)- 01Cabotegravir for HIV Prevention in Cisgender Men and Transgender WomenArticle893 citations2021
- 02Treatment of SyphilisArticle301 citations2014
- 03Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse PersonsArticle261 citations2024
- 04
- 05
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
iasusa.org/going-anti-viral-podcast
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →iasusa.org ↗ - Other
technologynetworks.com/tn/editor/dr-meredith-clement
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →technologynetworks.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.lsuhsc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.lsuhsc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.lsuhsc.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medschool.lsuhsc.edu ↗
- Board Certified
Internal Medicine (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lcmchealth.org ↗ - Board Certified
Infectious Disease (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →lcmchealth.org ↗
Editorial & leadership roles
journal and society appointments- Faculty
IAS-USA HIV/HCV continuing medical education program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iasusa.org ↗
Secondary affiliations
appointments beyond the home institution- University Medical Center New Orleans
Infectious Diseases (ID) Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.lsuhsc.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medschool.lsuhsc.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lcmchealth.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Efrain Reisin, MD
Louisiana State University Health Sciences Center New Orleans
Abraham Gedalia, MD
Louisiana State University Health Sciences Center New Orleans
Peter Boggs, MD
Louisiana State University Health Sciences Center New Orleans
Jayne Weiss, MD
Louisiana State University Health Sciences Center New Orleans
Yousef Khader
Jordan University of Science and Technology
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Derrick W. Crook
Nuffield Orthopaedic Centre